News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genomics Company Illumigen Biosciences, Inc. Completes $12 Million Recap Round



4/28/2006 11:39:50 AM

4/28/2006 – Hoping to harness the properties of beneficial genetic mutations for new therapies, Illumigen Biosciences Inc. closed a $12 million recapitalization, which includes about $8 million in new money, VentureWire has learned.




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES